Gary Gilkeson to Disease Progression
This is a "connection" page, showing publications Gary Gilkeson has written about Disease Progression.
Connection Strength
0.291
-
The United States to Africa lupus prevalence gradient revisited. Lupus. 2011 Oct; 20(10):1095-103.
Score: 0.076
-
New therapies and preventive strategies to treat and minimize damage in lupus. Curr Rheumatol Rep. 2005 Dec; 7(6):457-62.
Score: 0.051
-
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.
Score: 0.047
-
Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice. J Autoimmun. 2020 03; 108:102420.
Score: 0.034
-
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2467-75.
Score: 0.018
-
Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clin Exp Immunol. 2010 May; 160(2):275-82.
Score: 0.017
-
The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J Autoimmun. 2008 Sep; 31(2):123-30.
Score: 0.015
-
Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum. 2007 Aug 15; 57(6):993-9.
Score: 0.014
-
Genomic view of systemic autoimmunity in MRLlpr mice. Genes Immun. 2006 Mar; 7(2):156-68.
Score: 0.013
-
Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am. 1997 Jan; 81(1):113-28.
Score: 0.007